Pharmacokinetics-Pharmacodynamics of Enmetazobactam Combined with Cefepime in a Neutropenic Murine Thigh Infection Model.


Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
21 05 2020
Historique:
received: 24 01 2020
accepted: 29 03 2020
pubmed: 8 4 2020
medline: 22 6 2021
entrez: 8 4 2020
Statut: epublish

Résumé

Third-generation cephalosporin (3GC)-resistant

Identifiants

pubmed: 32253212
pii: AAC.00078-20
doi: 10.1128/AAC.00078-20
pmc: PMC7269482
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Azabicyclo Compounds 0
Cephalosporins 0
Triazoles 0
Cefepime 807PW4VQE3
enmetazobactam 80VUN7L00C
beta-Lactamases EC 3.5.2.6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2020 American Society for Microbiology.

Références

Antimicrob Agents Chemother. 2003 May;47(5):1643-6
pubmed: 12709334
Hum Mutat. 2016 Jun;37(6):564-9
pubmed: 26931183
Antimicrob Agents Chemother. 2015;59(6):3606-10
pubmed: 25801558
Int J Antimicrob Agents. 2019 May;53(5):557-558
pubmed: 30880227
Curr Opin Pharmacol. 2017 Oct;36:107-113
pubmed: 29128853
Antimicrob Agents Chemother. 2019 Apr 25;63(5):
pubmed: 30833428
Curr Opin Pharmacol. 2017 Oct;36:94-99
pubmed: 28964956
J Clin Microbiol. 2019 Jul 26;57(8):
pubmed: 31167844
Microbiol Mol Biol Rev. 2016 Jun 15;80(3):629-61
pubmed: 27307579
JAMA. 2018 Sep 11;320(10):979-981
pubmed: 30208439
Lancet Glob Health. 2018 Sep;6(9):e969-e979
pubmed: 30103998
Antimicrob Agents Chemother. 2019 Jun 24;63(7):
pubmed: 30988152
Antimicrob Agents Chemother. 2017 Aug 24;61(9):
pubmed: 28630197
J Infect. 2007 May;54(5):463-8
pubmed: 17067681
Antimicrob Agents Chemother. 1992 Nov;36(11):2439-43
pubmed: 1489186
Antimicrob Agents Chemother. 2013 Jun;57(6):2809-14
pubmed: 23629705
Antimicrob Agents Chemother. 2015 May;59(5):2688-94
pubmed: 25712356
Antimicrob Agents Chemother. 2019 Apr 25;63(5):
pubmed: 30833427
Antimicrob Agents Chemother. 2017 Mar 24;61(4):
pubmed: 28137811
Pharmacotherapy. 2019 Feb;39(2):182-195
pubmed: 30589457
Int J Antimicrob Agents. 2020 Feb 18;:105925
pubmed: 32084512
J Clin Microbiol. 2005 Aug;43(8):4178-82
pubmed: 16081970
Clin Microbiol Rev. 2019 May 15;32(3):
pubmed: 31092506
Antimicrob Agents Chemother. 2017 Nov 22;61(12):
pubmed: 28947475
Antimicrob Agents Chemother. 2020 May 21;64(6):
pubmed: 32253209
Curr Opin Pharmacol. 2017 Oct;36:viii-xii
pubmed: 29246371
J Bacteriol. 2012 Apr;194(7):1841-2
pubmed: 22408243
Clin Microbiol Infect. 2019 Aug;25(8):932-942
pubmed: 30986558
BMC Res Notes. 2019 Sep 23;12(1):611
pubmed: 31547853
Nucleic Acids Res. 2019 Jul 2;47(W1):W636-W641
pubmed: 30976793
J Antimicrob Chemother. 2017 Sep 1;72(9):2410-2417
pubmed: 28637307
Antimicrob Agents Chemother. 2016 Nov 21;60(12):7272-7279
pubmed: 27671063
Antimicrob Agents Chemother. 2019 Apr 25;63(5):
pubmed: 30858223
Antimicrob Agents Chemother. 2015 Nov 09;60(1):515-21
pubmed: 26552975
Lancet Infect Dis. 2018 Mar;18(3):318-327
pubmed: 29276051
Open Forum Infect Dis. 2019 Mar 15;6(Suppl 1):S23-S33
pubmed: 30895212
Curr Opin Microbiol. 2018 Oct;45:131-139
pubmed: 29723841
Clin Infect Dis. 2017 Apr 1;64(7):972-980
pubmed: 28362938
Antimicrob Agents Chemother. 2018 Sep 24;62(10):
pubmed: 30061284
Brief Bioinform. 2018 May 1;19(3):495-505
pubmed: 28013236

Auteurs

Fabian Bernhard (F)

LYO-X GmbH, Allschwil, Switzerland.

Rajesh Odedra (R)

Evotec (UK) Ltd., Cheshire, United Kingdom.

Sylvie Sordello (S)

Evotec (UK) Ltd., Cheshire, United Kingdom.

Rossella Cardin (R)

Aptuit (Verona) Srl, Verona, Italy.

Samantha Franzoni (S)

Aptuit (Verona) Srl, Verona, Italy.

Cédric Charrier (C)

IHMA Europe Sàrl, Monthey, Switzerland.

Adam Belley (A)

Allecra Therapeutics SAS, Saint-Louis, France.

Peter Warn (P)

Evotec (UK) Ltd., Cheshire, United Kingdom.

Matthias Machacek (M)

LYO-X GmbH, Allschwil, Switzerland.

Philipp Knechtle (P)

Allecra Therapeutics SAS, Saint-Louis, France phk@allecra.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH